Dhunputh C, Strullu M, Petit A, Merched M, et al. Single-dose (4.5 mg/m(2) ) gemtuzumab ozogamicin in combination with fludarabine, cytarabine and anthracycline as reinduction therapy in relapsed or refractory paediatric acute myeloid leukaemia. Br J Haematol 2022;198:373-381.
PMID: 35438187